Dongwha Pharm.Co.,Ltd (KRX:000020)

Market Cap	171.30B
Revenue (ttm)	493.33B
Net Income (ttm)	7.59B
Shares Out	27.72M
EPS (ttm)	273.72
PE Ratio	22.58
Forward PE	n/a
Dividend	180.00 (2.96%)
Ex-Dividend Date	Dec 29, 2025

Volume	48,891
Average Volume	69,870
Open	6,130.00
Previous Close	6,090.00
Day's Range	6,100.00 - 6,220.00
52-Week Range	5,600.00 - 7,140.00
Beta	0.32
RSI	46.78
Earnings Date	Nov 13, 2025

About Dongwha Pharm.Co.,Ltd

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health su...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1897
• Employees: 812
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 000020

Financial Performance

In 2024, Dongwha Pharm.Co.,Ltd's revenue was 464.87 billion, an increase of 28.74% compared to the previous year's 361.11 billion. Earnings were 5.56 billion, a decrease of -79.72%.